The Board of Directors of Malaysian Genomics Resource Centre Berhad ("MGRC" or "the Company") wishes to announce that the resolutionas set out in the Notice ofExtraordinary General Meeting ("EGM") dated 10November 2020 wasduly passed by the shareholders by way of poll voting at the EGMheld today. The details of the poll results are set out below.
The results of the poll were validated by Eco Asia Advisory Sdn. Bhd., the Independent Scrutineer appointed by the Company.
This announcement is dated 30 November 2020.
Voting Results |
||
1. Ordinary Resolution |
||
Description |
THAT approval be and is hereby granted to the Board of Directors of the Company ("Board") to diversify MGRC Group's principal activities to include biopharmaceutical and healthcare products and services. AND THAT the Board be and is hereby empowered and authorised to take all such steps and do all acts, deeds and things and enter into any arrangements, transactions, agreements and/or undertakings and to execute, sign and deliver on behalf of the Company, all such documents as the Board may deem necessary, expedient and/or appropriate to implement and give full effect to and to complete the Proposed Diversification with full powers to assent to any conditions, modifications, variations and/or amendments as the Board may in its absolute discretion deem fit, necessary, expedient, appropriate and/or as may be imposed or permitted by any relevant authorities in connection with the Proposed Diversification. |
|
Shareholder’s Action | For Voting | |
Voted | For | Against |
No. of Shareholders | 18 | 1 |
No. of Shares | 32,959,010 | 100 |
% of Voted Shares | 99.9997 | 0.0003 |
Result | Accepted | |